Skip to main content

Table 2 Case series of BCA previously published between 2007 and August 2022

From: Basal cell adenoma and basal cell adenocarcinoma of the parotid gland: clinical findings and surgical outcomes in a single-institution study

Authors (country)

N

Mean age (range)

Gender

Mean of tumor size (cm)

Site

Histopathological subtypes

Recurrence

Wilson et al. (USA) [11]

41

58 (14–86)

F = 24

M = 17

1.9

Parotid gland = 33

Oral cavity = 6

Submandibular gland = 1

Pharynx = 1

Trabecular = 25

Membranous = 6

Solid = 5

Tubular = 5

2/30 (6.7%)

Lu et al. (China) [19]

29*

57.0 (32–83)

F = 15

M = 13

2.08

Parotid gland = 29

Solid = 17

Tubular = 6

Trabecular = 4

Membranous = 2

0

Shi et al. (China) [32]

22

51.5 (32–73)

F = 16

M = 6

1.89

Parotid gland = 22

NI

NI

Lee et al. (Taiwan) [33]

41

54** (34–81)

F = 27

M = 14

1.5**

Parotid gland = 40

Pharynx = 1

Tubulotrabecular = 23

Trabecular = 11

Solid = 4

Cribriform = 3

NI

Cordeiro et al. (Brazil) [34]

30

66.1 (42–86)

F = 21

M = 9

3

Parotid gland = 28

Submandibular gland = 1

Upper lip = 1

Trabecular = 15

Solid = 8

Tubular = 7

0***

Terada et al. (Japan) [7]

45

58 (22–80)

F = 38

M = 7

2.2

Parotid gland = 45

NI

NI

Rito et al. (Portugal) [18]

38

62.4 (NI)

F = 21

M = 17

2.1

Parotid gland = 37

Minor gland = 1

Mixed = 30

Trabecular = 8

0

  1. BCA Basal cell adenoma, N Number of cases, F Female, M Male, NI not informed
  2. * One case was bilateral
  3. ** Median informed
  4. *** Patient did not present new tumor recurrence